Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue (Gross)
Ratios

Serina Therapeutics (SER) Receivables - Net (2017 - 2024)

Serina Therapeutics' Receivables - Net history spans 8 years, with the latest figure at $65000.0 for Q1 2024.

  • For Q1 2024, Receivables - Net rose 983.33% year-over-year to $65000.0; the TTM value through Mar 2024 reached $65000.0, up 983.33%, while the annual FY2023 figure was $57000.0, 1325.0% up from the prior year.
  • Receivables - Net for Q1 2024 was $65000.0 at Serina Therapeutics, up from $57000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $366000.0 in Q1 2020 and bottomed at $1000.0 in Q3 2022.
  • The 5-year median for Receivables - Net is $36500.0 (2021), against an average of $93375.0.
  • The largest annual shift saw Receivables - Net crashed 95.83% in 2022 before it surged 6600.0% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $326000.0 in 2020, then crashed by 92.33% to $25000.0 in 2021, then tumbled by 84.0% to $4000.0 in 2022, then surged by 1325.0% to $57000.0 in 2023, then grew by 14.04% to $65000.0 in 2024.
  • Per Business Quant, the three most recent readings for SER's Receivables - Net are $65000.0 (Q1 2024), $57000.0 (Q4 2023), and $67000.0 (Q3 2023).